Sreeni Sivan Pillai: When Hemostasis Fails: How Coagulopathy Disrupts the Body’s Most Critical Safety System
Sreeni Sivan Pillai, Technical Incharge/Interventional and Endovascular Radiology Systems Strategist, Outcome Architect at Narayana Health, shared on LinkedIn:
“When Hemostasis Fails: How Coagulopathy Disrupts the Body’s Most Critical Safety System
Hemostasis is one of the most elegant protective mechanisms in human physiology—quiet, precise, and life-saving. Yet, when coagulopathy sets in, this system can collapse within minutes, turning simple procedures into high-risk events.
As clinicians, technicians, and interventionists, understanding how and where this breakdown happens is not just academic—it directly determines patient outcomes in the cath lab, hybrid OR, trauma bay and ICU.
The Real Problem: Coagulopathy Disrupts Hemostasis at Every Level
1. Primary Hemostasis – The Platelet Plug Fails
Coagulopathy can impair platelet function or reduce platelet numbers.
This leads to:
Poor adhesion and aggregation
Persistent oozing during vascular access
Fragile initial clot formation
Practical impact: Even a well-compressed access site may continue to bleed because the platelet foundation itself is weak.
2.Secondary Hemostasis – The Coagulation Cascade Stalls
Factor deficiency (Liver disease, DIC, dilutional coagulopathy, anticoagulation) disrupts the thrombin burst, resulting in:
Slow or incomplete fibrin formation
Difficulty achieving procedural hemostasis
Increased risk during sheath removal or post-angioplasty
Practical insight: When thrombin generation is inadequate, compression alone cannot stop bleeding—the clot simply has no structural strength.
3. Fibrin Stability – The Clot Is Built but Breaks Apart
Conditions like hyperfibrinolysis or Factor XIII deficiency cause early lysis of formed clots.
Clinical signals:
Recurrent bleeding after initial control
Hematoma formation despite normal platelets
Soft, unstable clot on visual assessment
Why it matters: A clot that dissolves too early is often mistaken for “technical bleeding,” when the true culprit is biochemical.
Dysregulated Anticoagulant Pathways – The Balance Tips Too Far
Excess activation of natural anticoagulants (Protein C/S, antithrombin, tPA) or iatrogenic anticoagulation suppresses thrombin generation.
Real-world risk:
Even low-intensity procedural manipulations can cause disproportionate bleeding.
Why This Matters in Daily Practice
In the vascular suite or cath lab, coagulopathy reveals itself subtly:
Persistent oozing at access sites
Difficulty securing hemostasis after sheath removal
Hematoma despite correct compression technique
Unexplained drop in hemoglobin
Abnormal TEG/ROTEM patterns that predict instability
Recognizing these clues early transforms outcomes.
Coagulopathy isn’t a single defect—it is a multilevel failure of hemostasis, disrupting:
Platelet plug formation
Coagulation factor activity
Fibrin stability
Regulatory balance
And when these systems fail, the stability of every procedure—from simple cannulation to complex endovascular work—is at risk”
More posts about Hemostasis on Hemostasis Today.
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
-
Jan 12, 2026, 01:45Khurram Nasir on Where The Cholesterol Guidelines Are Headed
-
Jan 12, 2026, 01:35Nirav Dhanesha Shares The Lab’s Latest Publication on Neutrophil CD14 and DVT Link
-
Jan 12, 2026, 01:07Akshat Jain Presents The New Edition of Global Sickle Cell Disease Insight Publication
-
Jan 11, 2026, 21:05Simona Sacco Shares Expert Guidance for Clinicians on Minor Ischemic Stroke
-
Jan 11, 2026, 11:00Benjamin YQ Tan on Impacts of Early Cognitive and Psychological Statuses Post-Stroke
-
Jan 11, 2026, 10:46Salvador Payán Pernía: Leukodepletion Reduces Microplastic Burden in Red Blood Cell Concentrates
-
Jan 11, 2026, 10:36Mariasanta Napolitano on Pregnancy and Delivery Outcomes in Women with Hemophilia